E. coli News and Research RSS Feed - E. coli News and Research

E. coli or Escherichia coli is the name of a type of bacteria that lives in your intestines. Most types of E. coli are harmless. However, some types can make you sick and cause diarrhea. One type causes travelers' diarrhea. The worst type of E. coli causes bloody diarrhea, and can sometimes cause kidney failure and even death. These problems are most likely to occur in children and in adults with weak immune systems. You can get E. coli infections by eating foods containing the bacteria. To help avoid food poisoning and prevent infection, handle food safely. Cook meat well, wash fruits and vegetables before eating or cooking them, and avoid unpasteurized milk and juices. You can also get the infection by swallowing water in a swimming pool contaminated with human waste. Most cases of E. coli infection get better without treatment in 5 to 10 days.
Researchers examine effects of bacteria in fighting against obesity

Researchers examine effects of bacteria in fighting against obesity

A probiotic that prevents obesity could be on the horizon. Bacteria that produce a therapeutic compound in the gut inhibit weight gain, insulin resistance and other adverse effects of a high-fat diet in mice, Vanderbilt University investigators have discovered. [More]
Researchers seek ways to prevent foodborne illnesses with cinnamon

Researchers seek ways to prevent foodborne illnesses with cinnamon

Seeking ways to prevent some of the most serious foodborne illnesses caused by pathogenic bacteria, two Washington State University scientists have found promise in an ancient but common cooking spice: cinnamon. [More]
Bubble wrap offers numerous advantages for people living in resource-limited areas

Bubble wrap offers numerous advantages for people living in resource-limited areas

Popping the blisters on the bubble wrap might be the most enjoyable thing about moving. But now, scientists propose a more productive way to reuse the popular packing material - as a sheet of small, test tube-like containers for medical and environmental samples. [More]
Novagant releases GoldenCBD oil including capsules and liquids

Novagant releases GoldenCBD oil including capsules and liquids

Novagant Corp. is pleased to announce that in this month of July it will release its GoldenCBD™ oil that will be available in several forms, including capsules and liquids. It will be the answer for those Medical Cannabis Patients living outside Washington and Colorado. [More]
Biochemists find groups of tiny protein loops that help bacteria to establish infection

Biochemists find groups of tiny protein loops that help bacteria to establish infection

When it comes to infecting humans and animals, bacteria need a helping hand. Kansas State University biochemists have found the helping hand: groups of tiny protein loops on the surface of cells. [More]
Scientists develop new weapon against bacterial infections in the form of tiny DNA pyramids

Scientists develop new weapon against bacterial infections in the form of tiny DNA pyramids

Bacterial infections usually announce themselves with pain and fever but often can be defeated with antibiotics - and then there are those that are sneaky and hard to beat. Now, scientists have built a new weapon against such pathogens in the form of tiny DNA pyramids. [More]
Sigma-Tau Rare Disease seeks EMA approval for use of Oncaspar for ALL treatment

Sigma-Tau Rare Disease seeks EMA approval for use of Oncaspar for ALL treatment

Sigma Tau Pharma Ltd. (hereinafter referred to as Sigma-Tau Rare Disease), today announced the submission of an application to the European Medicines Agency for use of its pegylatedL-asparaginase, Oncaspar (pegaspargase) for the treatment of Acute Lymphoblastic Leukaemia (ALL) as part of a multi-agent chemotherapeutic regimen. [More]
New pathway to disabling disease: blocking bacteria's access to iron in the body

New pathway to disabling disease: blocking bacteria's access to iron in the body

In an era of increasing concern about the prevalence of antibiotic-resistant illness, Case Western Reserve researchers have identified a promising new pathway to disabling disease: blocking bacteria's access to iron in the body. [More]
Researcher describes possible implications of increased gravity effect on immunity

Researcher describes possible implications of increased gravity effect on immunity

Before you swat away the next fruit fly, consider instead just how similar its biological complexities are to our own. [More]
Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation. [More]
Delphi Genetics announces new license agreement for use of StabyExpress technology in food industry

Delphi Genetics announces new license agreement for use of StabyExpress technology in food industry

Delphi Genetics SA has announced today a new license agreement for the use of the StabyExpress® technology in the food industry. The technology will be used for the production of enzymes for food processing. [More]
New project improves techniques for detecting E. coli

New project improves techniques for detecting E. coli

Kansas State University diagnosticians are helping the cattle industry save millions of dollars each year by developing earlier and accurate detection of E. coli. [More]
New methods for detection of fecal pollution in Norwegian watercourses

New methods for detection of fecal pollution in Norwegian watercourses

The Norwegian Institute for Agricultural and Environmental Research, Bioforsk, has tested and implemented a set of methods for the detection of fecal pollution in Norwegian watercourses. [More]
Novel technology to block human infections receives I-Corps grant

Novel technology to block human infections receives I-Corps grant

A novel technology developed at Worcester Polytechnic Institute (WPI) to block human infections by taking a lesson from fish has landed a $50,000 grant from the National Science Foundation's Innovation Corps (I-Corps) program. [More]
Findings have important implications for improving war wound healing

Findings have important implications for improving war wound healing

War wounds that heal successfully frequently contain different microbial species from those that heal poorly, according to a paper published ahead of print in the Journal of Clinical Microbiology. [More]
Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

A drug's half-life indicates how long a substance will remain active in the body. It is essentially the period of time that it takes for the concentration of the amount of the drug to be reduced by half, and therefore, determines how frequently a drug needs to be administered to maintain its therapeutic effect. [More]
Researchers identify small molecule that prevents bacteria from forming into infectious biofilms

Researchers identify small molecule that prevents bacteria from forming into infectious biofilms

Researchers at the University of British Columbia have identified a small molecule that prevents bacteria from forming into biofilms, a frequent cause of infections. [More]
Disease-causing bacteria can linger in airplane cabins for days, says study

Disease-causing bacteria can linger in airplane cabins for days, says study

Disease-causing bacteria can linger on surfaces commonly found in airplane cabins for days, even up to a week, according to research presented at the annual meeting of the American Society for Microbiology. [More]

Biótica researchers develop automated laboratory system that rapidly detects E. coli bacterium

A Castellón-based biotechnology R&D project by Biótica has been successfully certified by the Centre for Technological and Industrial Development (CDTI, in Spanish), of the Spanish Ministry of Economy and Competitiveness. [More]
S. pneumoniae interacts with other nasopharyngeal bacteria

S. pneumoniae interacts with other nasopharyngeal bacteria

Streptococcus pneumoniae bacteria are able to detect and respond to other bacterial species in the same host niche, researchers report in Open Biology. [More]